CORDIS
EU research results

CORDIS

English EN

Highly Competent and Safe Titanium(IV) Therapeutic Frameworks that are Cancer Targeted based on Complex 1, 2, and 3D Chemical Architectures

Periodic Reporting for period 2 - TiDrugArchitectures (Highly Competent and Safe Titanium(IV) Therapeutic Frameworks that are Cancer Targeted based on Complex 1, 2, and 3D Chemical Architectures)

Reporting period: 2017-12-01 to 2019-05-31

Project information

Grant agreement ID: 681243

Status

Ongoing project

  • Start date

    1 June 2016

  • End date

    31 May 2021

Funded under:

H2020-EU.1.1.

  • Overall budget:

    € 2 000 000

  • EU contribution

    € 2 000 000

Hosted by:

THE HEBREW UNIVERSITY OF JERUSALEM